SPL 0.00% 9.4¢ starpharma holdings limited

ARTG Astodrimer sodium Nasal Spray to be included by September, page-9

  1. 3,505 Posts.
    lightbulb Created with Sketch. 836
    So much is wrong with this misleading thread.

    The thread title clearly and misleadingly infers that marketing approval for Viraleze has been given whereas in reality land, the TGA is yet to make a decision which is up to 8 weeks away.

    And then the chief pumper chimes in with:
    ’Targeting baby boomers on cruise ships would be an ideal cohort for Viraleze’

    Sorry to break it to you captain, but the world’s largest baby boomer consumer market for cruise ships is Europe. Viraleze has been approved and marketed in this market since 2021 with peanuts to show for it.

    Starpharma have missed this boat. And to add an extra sting in the face, long suffering shareholders have paid for it. $2.50 to 8.6 cents is quite the voyage.
    Last edited by sarge17: 20/07/24
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
(20min delay)
Last
9.4¢
Change
0.000(0.00%)
Mkt cap ! $39.30M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
1 3803 9.9¢
 

Sellers (Offers)

Price($) Vol. No.
9.5¢ 56056 2
View Market Depth
Last trade - 09.12am 01/11/2024 (20 minute delay) ?
SPL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.